Profile
John Babiak worked as a Director of Robotics & Screening at Wyeth-Ayerst Research from 1999 to 1999.
He then worked as a Vice President of Technology at Pharmacopeia LLC from 1999 to 2001.
Later, he worked as a Senior VP of Drug Discoveries Technologies at PTC Therapeutics, Inc. from 2012 to 2013.
Dr. Babiak received his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California, Berkeley.
Former positions of John Babiak
Companies | Position | End |
---|---|---|
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Chief Tech/Sci/R&D Officer | 2001-08-31 |
Wyeth-Ayerst Research | Corporate Officer/Principal | 1999-02-28 |
PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of John Babiak
University of California, Berkeley | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Wyeth-Ayerst Research |
- Stock Market
- Insiders
- John Babiak